<DOC>
	<DOCNO>NCT00975078</DOCNO>
	<brief_summary>Suppression adrenal function common , potentially dangerous unpredictable consequence short term high dose glucocorticoid treatment . Identification patient risk would high clinical importance . The investigator hypothesize dexamethasone-suppression-test predicts subsequent development corticosteroid induce adrenal insufficiency .</brief_summary>
	<brief_title>Test Predicting Adrenal Insufficiency Volunteers Under Prednisone Treatment</brief_title>
	<detailed_description>The objective study evaluate adrenal axis integrity investigate dexamethasone-suppression-test predict development adrenal insufficiency 14 day treatment 0.5mg/kg body weight prednisone healthy volunteer . The investigator hypothesize subject suppress cortisol level dexamethasone likely develop adrenal insufficiency 14 day intake prednisone o.5mg/kg/body weight subject le suppression cortisol level dexamethasone .</detailed_description>
	<mesh_term>Adrenal Insufficiency</mesh_term>
	<mesh_term>Addison Disease</mesh_term>
	<mesh_term>Dexamethasone acetate</mesh_term>
	<mesh_term>Dexamethasone</mesh_term>
	<mesh_term>Prednisone</mesh_term>
	<mesh_term>Dexamethasone 21-phosphate</mesh_term>
	<mesh_term>BB 1101</mesh_term>
	<mesh_term>Epinephrine</mesh_term>
	<mesh_term>Racepinephrine</mesh_term>
	<mesh_term>Epinephryl borate</mesh_term>
	<criteria>Healthy male volunteer 18 year No informed consent Intake kind medication BMI 30kg/m2 Acute chronic illness</criteria>
	<gender>Male</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>August 2011</verification_date>
	<keyword>dexamethasone-suppression-test</keyword>
	<keyword>high dose glucocorticoid treatment</keyword>
	<keyword>Population Risk</keyword>
</DOC>